Scopus BioPharma jumps after retaining counsel to probe share fall

Scopus Biopharma

01/10/2021 22:01

** Drug developer's shares  SCPS.O  up nearly 30% at $1.15
in extended trading 
    ** Says it has retained an outside counsel to conduct a
market manipulation investigation  urn:newsml:reuters.com:*:nGNX34rfVR
    ** SCPS shares have fallen 72% YTD, and co attributes a
recent fall in share price to short sellers 
    ** Short interest in SCPS is about $265,000, roughly 1.5% of
co's floating shares, according to S3 Partners
    ** Co had a market capitalization of $75.1 mln, as of its
last closing price 


 (Reporting by Manas Mishra)
 ((Manas.Mishra@thomsonreuters.com;
www.twitter.com/Manasmishra24))